SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-294051
Filing Date
2011-11-03
Accepted
2011-11-03 08:10:56
Documents
4
Period of Report
2011-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d251413d8k.htm 8-K 16420
2 PRESS RELEASE d251413dex991.htm EX-99.1 569611
3 GRAPHIC g251413g51e19.jpg GRAPHIC 3946
4 GRAPHIC g251413g93x45.jpg GRAPHIC 5141
  Complete submission text file 0001193125-11-294051.txt   600204
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 111176133
SIC: 2834 Pharmaceutical Preparations